Cargando…
A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer
Ovarian cancer affects >295,000 women worldwide and is the most lethal of gynaecological malignancies. Often diagnosed at a late stage, current research efforts seek to further the molecular understanding of its aetiopathogenesis and the development of novel biomarkers. The present study investig...
Autores principales: | Kerslake, Rachel, Hall, Marcia, Vagnarelli, Paola, Jeyaneethi, Jeyarooban, Randeva, Harpal S., Pados, George, Kyrou, Ioannis, Karteris, Emmanouil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298991/ https://www.ncbi.nlm.nih.gov/pubmed/34386072 http://dx.doi.org/10.3892/ol.2021.12911 |
Ejemplares similares
-
Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer
por: Kerslake, Rachel, et al.
Publicado: (2022) -
Involvement of the glutamine RF-amide peptide and its cognate receptor GPR103 in prostate cancer
por: Kawan, Mohamed Ab., et al.
Publicado: (2019) -
Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian Cancer
por: Kerslake, Rachel, et al.
Publicado: (2022) -
Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro
por: Filipe, Alice, et al.
Publicado: (2022) -
Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway
por: Shabir, Kiran, et al.
Publicado: (2022)